Human ARSB ELISA Kit (V2LY-0626-LY5889)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Sensitivity
0.026 ng/mL
Detection Range
0.05-20 ng/mL
Sample Type
Serum, Plasma, cell culture supernates
Specificity
Human
Assay Type
Sandwich
Reactivity
Human
Assay Time
1.5 h
Molecule Mass
59.7 kDa
Components
  • Pre-coated ELISA Plate: 12 wells * 8 detachable strips
  • Standard solution: 0.5ml x1
  • Standard diluent: 3ml x1
  • Streptavidin-HRP: 6ml x1
  • Stop solution: 6ml x1
  • Substrate solution A: 6ml x1
  • Substrate solution B: 6ml x1
  • Wash buffer concentrate (25x): 20ml x1
  • Biotinylated antibody: 1ml x1

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at 2-8°C
More Infomation

Target

Full Name
arylsulfatase B
Function
Removes sulfate groups from chondroitin-4-sulfate (C4S) and regulates its degradation (PubMed:19306108).
Involved in the regulation of cell adhesion, cell migration and invasion in colonic epithelium (PubMed:19306108).
In the central nervous system, is a regulator of neurite outgrowth and neuronal plasticity, acting through the control of sulfate glycosaminoglycans and neurocan levels (By similarity).
Biological Process
Autophagy Source: Ensembl
Central nervous system development Source: Ensembl
Chondroitin sulfate catabolic process Source: Reactome
Colon epithelial cell migration Source: UniProtKB
Lysosomal transport Source: ProtInc
Lysosome organization Source: ProtInc
Neutrophil degranulation Source: Reactome
Positive regulation of neuron projection development Source: UniProtKB
Regulation of epithelial cell migration Source: UniProtKB
Response to estrogen Source: Ensembl
Response to methylmercury Source: Ensembl
Response to nutrient Source: Ensembl
Response to pH Source: Ensembl
Cellular Location
Lysosome; Cell surface
Involvement in disease
Mucopolysaccharidosis 6 (MPS6): An autosomal recessive lysosomal storage disease characterized by intracellular accumulation of dermatan sulfate. Clinical features can include abnormal growth, short stature, stiff joints, skeletal malformations, corneal clouding, hepatosplenomegaly, and cardiac abnormalities. A wide variation in clinical severity is observed.
Multiple sulfatase deficiency (MSD): The protein represented in this entry is involved in disease pathogenesis. Arylsulfatase B activity is impaired in multiple sulfatase deficiency due to mutations in SUMF1. SUMF1 mutations result in defective post-translational modification of ARSB at residue Cys-91 that is not converted to 3-oxoalanine. A clinically and biochemically heterogeneous disorder caused by the simultaneous impairment of all sulfatases, due to defective post-translational modification and activation. It combines features of individual sulfatase deficiencies such as metachromatic leukodystrophy, mucopolysaccharidosis, chondrodysplasia punctata, hydrocephalus, ichthyosis, neurologic deterioration and developmental delay.
PTM
The conversion to 3-oxoalanine (also known as C-formylglycine, FGly), of a serine or cysteine residue in prokaryotes and of a cysteine residue in eukaryotes, is critical for catalytic activity. This post-translational modification is severely defective in multiple sulfatase deficiency (MSD).

Bhattacharyya, S., Feferman, L., Han, X., Xia, K., Zhang, F., Linhardt, R. J., & Tobacman, J. K. (2020). Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: potential impact on epithelial and mesenchymal identity. Oncotarget, 11(24), 2327.

Hendrickx, G., Danyukova, T., Baranowsky, A., Rolvien, T., Angermann, A., Schweizer, M., ... & Schinke, T. (2020). Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes. Human molecular genetics, 29(5), 803-816.

Tobacman, J. K., Bhattacharyya, S., & Feferman, L. (2020). Increased CHST15 expression follows declines in Arylsulfatase B (ARSB) and DKK3 and disinhibition of non-canonical WNT signaling.

Aminzadeh, M., Malekpour, N., & Ghandil, P. (2019). Identification of arylsulfatase B gene mutations and clinical presentations of Iranian patients with Mucopolysaccharidosis VI. Gene, 706, 1-5.

Bhattacharyya, S., Feferman, L., & Tobacman, J. K. (2019). Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)‐3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A. The Prostate, 79(7), 689-700.

Pohl, S., Angermann, A., Jeschke, A., Hendrickx, G., Yorgan, T. A., Makrypidi‐Fraune, G., ... & Schinke, T. (2018). The lysosomal protein arylsulfatase B is a key enzyme involved in skeletal turnover. Journal of Bone and Mineral Research, 33(12), 2186-2201.

Bhattacharyya, S., Feferman, L., Han, X., Ouyang, Y., Zhang, F., Linhardt, R. J., & Tobacman, J. K. (2018). Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells. Journal of Biological Chemistry, 293(28), 11076-11087.

Essawi, M. L., Elbagoury, N. M., Sayed, O. M., Aglan, M. S., Ibrahim, M. M., Soliman, H. N., & Fateen, E. M. (2018). Mutation analysis of the arylsulfatase B gene among Egyptian patients with Maroteaux–Lamy disorder. Middle East Journal of Medical Genetics, 7(2), 96.

Zhang, J., Liang, H., Zhu, L., Gan, W., Tang, C., Li, J., & Xu, R. (2018). Expression and distribution of Arylsulfatase B are closely associated with neuron death in SOD1 G93A transgenic mice. Molecular neurobiology, 55(2), 1323-1337.

Bhattacharyya, S., Feferman, L., Terai, K., Dudek, A. Z., & Tobacman, J. K. (2017). Decline in arylsulfatase B leads to increased invasiveness of melanoma cells. Oncotarget, 8(3), 4169.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human ARSB ELISA Kit?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.